{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T16:22:01Z","timestamp":1778689321633,"version":"3.51.4"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,6,19]]},"DOI":"10.7759\/cureus.62736","type":"journal-article","created":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T06:37:56Z","timestamp":1718865476000},"source":"Crossref","is-referenced-by-count":2,"title":["Denosumab: A Useful Addition to the Armamentarium for the Management of Male Osteoporosis"],"prefix":"10.7759","author":[{"given":"Jijith","family":"Krishnan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sham","family":"Santhanam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhuwan","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salim","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Divya G","family":"Bhojwani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sameer","family":"Muchhala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.5534\/wjmh.200099","article-title":"Gender differences in osteoporosis: a single-center observational study","volume":"39","author":"De Martinis M","year":"2021","unstructured":"De Martinis M, Sirufo MM, Polsinelli M, Placidi G, Di Silvestre D, Ginaldi L. Gender differences in osteoporosis: a single-center observational study. World J Mens Health. 2021, 39:750-9. 10.5534\/wjmh.200099","journal-title":"World J Mens Health"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s11657-021-00954-1","article-title":"The Indian Society for Bone and Mineral Research (ISBMR) position statement for the diagnosis and treatment of osteoporosis in adults","volume":"16","author":"Bhadada SK","year":"2021","unstructured":"Bhadada SK, Chadha M, Sriram U, et al.. The Indian Society for Bone and Mineral Research (ISBMR) position statement for the diagnosis and treatment of osteoporosis in adults. Arch Osteoporos. 2021, 16:102. 10.1007\/s11657-021-00954-1","journal-title":"Arch Osteoporos"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.882241","article-title":"The Global Burden of osteoporosis, low bone mass, and its related fracture in 204 countries and territories, 1990-2019","volume":"13","author":"Shen Y","year":"2022","unstructured":"Shen Y, Huang X, Wu J, et al.. The Global Burden of osteoporosis, low bone mass, and its related fracture in 204 countries and territories, 1990-2019. Front Endocrinol (Lausanne). 2022, 13:882241. 10.3389\/fendo.2022.882241","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.18203\/issn.2455-4510","article-title":"Prevalence of osteoporosis in India: an observation of 31238 adults","volume":"7","author":"Babhulkar S","year":"2021","unstructured":"Babhulkar S, Seth S. Prevalence of osteoporosis in India: an observation of 31238 adults. Int J Res Orthop. 2021, 7:362-8. 10.18203\/issn.2455-4510","journal-title":"Int J Res Orthop"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222413640","article-title":"Management of osteoporosis in men: a narrative review","volume":"22","author":"Vescini F","year":"2021","unstructured":"Vescini F, Chiodini I, Falchetti A, et al.. Management of osteoporosis in men: a narrative review. Int J Mol Sci. 2021, 22:13640. 10.3390\/ijms222413640","journal-title":"Int J Mol Sci"},{"key":"ref6","article-title":"Osteoporosis in men","volume":"82","author":"Rao SS","year":"2010","unstructured":"Rao SS, Budhwar N, Ashfaque A. Osteoporosis in men. Am Fam Physician. 2010, 82:503-8.","journal-title":"Am Fam Physician"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.2147\/CIA.S51940","article-title":"Osteoporosis in men: epidemiology and treatment with denosumab","volume":"9","author":"Sidlauskas KM","year":"2014","unstructured":"Sidlauskas KM, Sutton EE, Biddle MA. Osteoporosis in men: epidemiology and treatment with denosumab. Clin Interv Aging. 2014, 9:593-601. 10.2147\/CIA.S51940","journal-title":"Clin Interv Aging"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3803\/EnM.2021.1369","article-title":"Discontinuing denosumab: Can it be done safely? A review of the literature","volume":"37","author":"Tay WL","year":"2022","unstructured":"Tay WL, Tay D. Discontinuing denosumab: Can it be done safely? A review of the literature. Endocrinol Metab (Seoul). 2022, 37:183-94. 10.3803\/EnM.2021.1369","journal-title":"Endocrinol Metab (Seoul)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-1569","article-title":"A randomized, placebo-controlled study of the effects of denosumab for the treatment of men with low bone mineral density","volume":"97","author":"Orwoll E","year":"2012","unstructured":"Orwoll E, Teglbj\u00e6rg CS, Langdahl BL, et al.. A randomized, placebo-controlled study of the effects of denosumab for the treatment of men with low bone mineral density. J Clin Endocrinol Metab. 2012, 97:3161-9. 10.1210\/jc.2012-1569","journal-title":"J Clin Endocrinol Metab"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/627631","article-title":"Denosumab for elderly men with osteoporosis: a cost-effectiveness analysis from the US payer perspective","volume":"2015","author":"Silverman S","year":"2015","unstructured":"Silverman S, Agodoa I, Kruse M, Parthan A, Orwoll E. Denosumab for elderly men with osteoporosis: a cost-effectiveness analysis from the US payer perspective. J Osteoporos. 2015, 2015:627631. 10.1155\/2015\/627631","journal-title":"J Osteoporos"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3904\/kjim.2022.064","article-title":"The efficacy of denosumab in Korean male patients with osteoporosis","volume":"37","author":"Jeong C","year":"2022","unstructured":"Jeong C, Ha J, Kim J, et al.. The efficacy of denosumab in Korean male patients with osteoporosis. Korean J Intern Med. 2022, 37:1011-20. 10.3904\/kjim.2022.064","journal-title":"Korean J Intern Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.4321\/S1889-836X2022000200005","article-title":"Effect of treatment with denosumab for 24 months in individuals with recent spinal cord injury with osteoporosis","volume":"14","author":"Gifre L","year":"2022","unstructured":"Gifre L, Vidal J, Carrasco JL, et al.. Effect of treatment with denosumab for 24 months in individuals with recent spinal cord injury with osteoporosis. Rev Osteoporos Metab Miner. 2022, 14:88-92. 10.4321\/S1889-836X2022000200005","journal-title":"Rev Osteoporos Metab Miner"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1055\/s-0029-1224109","article-title":"Efficacy and safety of denosumab in postmenopausal women with osteopenia or osteoporosis: a systematic review and a meta-analysis","volume":"41","author":"Anastasilakis AD","year":"2009","unstructured":"Anastasilakis AD, Toulis KA, Goulis DG, Polyzos SA, Delaroudis S, Giomisi A, Terpos E. Efficacy and safety of denosumab in postmenopausal women with osteopenia or osteoporosis: a systematic review and a meta-analysis. Horm Metab Res. 2009, 41:721-9. 10.1055\/s-0029-1224109","journal-title":"Horm Metab Res"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2011.03.005","article-title":"Clinical efficacy and safety of denosumab in postmenopausal women with low bone mineral density and osteoporosis: a meta-analysis","volume":"41","author":"von Keyserlingk C","year":"2011","unstructured":"von Keyserlingk C, Hopkins R, Anastasilakis A, Toulis K, Goeree R, Tarride JE, Xie F. Clinical efficacy and safety of denosumab in postmenopausal women with low bone mineral density and osteoporosis: a meta-analysis. Semin Arthritis Rheum. 2011, 41:178-86. 10.1016\/j.semarthrit.2011.03.005","journal-title":"Semin Arthritis Rheum"},{"key":"ref15","article-title":"Safety of denosumab in postmenopausal women with osteoporosis or low bone mineral density: a meta-analysis","volume":"7","author":"Zhou Z","year":"2014","unstructured":"Zhou Z, Chen C, Zhang J, et al.. Safety of denosumab in postmenopausal women with osteoporosis or low bone mineral density: a meta-analysis. Int J Clin Exp Pathol. 2014, 7:2113-22.","journal-title":"Int J Clin Exp Pathol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000001674","article-title":"Efficacy and safety of denosumab in postmenopausal women with osteoporosis: a meta-analysis","volume":"94","author":"Gu HF","year":"2015","unstructured":"Gu HF, Gu LJ, Wu Y, Zhao XH, Zhang Q, Xu ZR, Yang YM. Efficacy and safety of denosumab in postmenopausal women with osteoporosis: a meta-analysis. Medicine (Baltimore). 2015, 94:e1674. 10.1097\/MD.0000000000001674","journal-title":"Medicine (Baltimore)"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-021-01936-y","article-title":"Denosumab in the treatment of osteoporosis: 10 years later: a narrative review","volume":"39","author":"Kendler DL","year":"2022","unstructured":"Kendler DL, Cosman F, Stad RK, Ferrari S. Denosumab in the treatment of osteoporosis: 10 years later: a narrative review. Adv Ther. 2022, 39:58-74. 10.1007\/s12325-021-01936-y","journal-title":"Adv Ther"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S270829","article-title":"A review on the role of denosumab in fracture prevention","volume":"14","author":"Pang KL","year":"2020","unstructured":"Pang KL, Low NY, Chin KY. A review on the role of denosumab in fracture prevention. Drug Des Devel Ther. 2020, 14:4029-51. 10.2147\/DDDT.S270829","journal-title":"Drug Des Devel Ther"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1517\/17425255.2015.1000860","article-title":"Denosumab for the treatment of osteoporosis","volume":"11","author":"Zaheer S","year":"2015","unstructured":"Zaheer S, LeBoff M, Lewiecki EM. Denosumab for the treatment of osteoporosis. Expert Opin Drug Metab Toxicol. 2015, 11:461-70. 10.1517\/17425255.2015.1000860","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"ref20","unstructured":"ACR\/ARP medication guide. denosumab. (2023). Accessed: February 11, 2023: https:\/\/rheumatology.org\/api\/asset\/blt6de55275d9c10373."},{"key":"ref21","unstructured":"Prolia denosumab injection. (2024). Accessed. June 8, 2024: https:\/\/www.proliahcp.com\/#fullIsi."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/232165-denosumab-a-useful-addition-to-the-armamentarium-for-the-management-of-male-osteoporosis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T06:38:01Z","timestamp":1718865481000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/232165-denosumab-a-useful-addition-to-the-armamentarium-for-the-management-of-male-osteoporosis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,19]]},"references-count":21,"URL":"https:\/\/doi.org\/10.7759\/cureus.62736","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6,19]]}}}